Online registration for this event is now closed. If you would like to register for this event, please contact Customer Service (800) 892-1400, Option 2.

Personalized Medicine: An Update on HER2 Testing is the second of twelve programs in the 2014 Clinical Chemistry Series of webinars. In 2013, ASCO and CAP released a guideline update that’s designed to help labs improve the accuracy of HER2 testing and its utility as a predictive marker in invasive breast cancer.  Attend this webinar and learn more about the new guideline, the role anti-HER2 therapy plays in the treatment of breast cancer, and the advantages and limitation of current HER2 testing technologies.